Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.4 USD | -0.43% | -5.45% | +20.21% |
24/05 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
24/05 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.21% | 2.14B | |
+9.57% | 3,073B | |
+7.71% | 85.98B | |
+4.48% | 78.37B | |
-16.13% | 52.7B | |
+25.95% | 47.48B | |
+30.24% | 45.54B | |
-32.67% | 41.5B | |
+70.37% | 39.83B | |
+1.78% | 28.05B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Earnings Flash (CLBT) CELLEBRITE DI Reports Q2 Revenue $76.7M, vs. Street Est of $72.5M